CAMK2N1 and prostate carcinoma: In a prior study, we demonstrated that CAMK2N1 expression was reduced in prostate cancer, and re-introduction of CAMK2N1 significantly impaired human prostate cancer cell proliferation and tumor growth in vivo [8].